The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlanbia Regulatory News (GLB)

Share Price Information for Glanbia (GLB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.50
Bid: 17.30
Ask: 18.50
Change: 0.41 (2.27%)
Spread: 1.20 (6.936%)
Open: 18.50
High: 18.50
Low: 18.50
Prev. Close: 18.09
GLB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

4 May 2023 07:05

RNS Number : 3454Y
Glanbia PLC
04 May 2023
 

Board Director appointment

 

4 May 2023, Glanbia plc, the better nutrition company, is announcing the appointment of Ms Gabriella Parisse to its Board as an Independent Non-Executive Director effective 1 June 2023. On appointment Gabriella will also join the Board Development Committee.

 

Gabriella brings to the Glanbia Board significant experience in consumer brand development, the food ingredients industry, innovation and strategic leadership of multinational businesses.

 

Gabriella is an Italian citizen and currently resides in the USA where she is President and CEO of Velcro Companies, a global manufacturer of innovative fastening solutions for a broad range of end markets. She has more than 35 years of international experience in consumer goods and business to business industries with a track-record in accelerating growth, brand building and innovation. For a significant proportion of her career she has been performing senior roles based in North America. Gabriella joined Velcro Companies in October 2018 as Chief Marketing Officer & President of the Consumer division, and prior to her appointment as CEO in 2021 served as Chief Growth Officer.

 

Since 2022, Gabriella also serves as a member of the New England Advisory Council of the Federal Reserve Bank of Boston.

 

Prior to Velcro Companies, Gabriella served on the Executive Committee of Tate & Lyle plc a global food ingredients business, as President, Innovation and Commercial Development, reporting to the CEO. Previously, Gabriella spent 26 years with Johnson & Johnson. She served in a variety of global senior leadership roles with increasing responsibility in marketing, innovation and business development, including President of Johnson & Johnson Consumer Italy and Vice President, Skincare for Europe, Africa and Middle East.

 

Gabriella holds a master's degree in Statistic & Demographic Sciences from La Sapienza University in Rome. In 2009, she was awarded the Order of Merit for Labor title ("Cavaliere del Lavoro") by the President of the Italian Republic.

 

Compliance with Listing Rules

Gabriella has notified Glanbia plc that, save as disclosed herein, she does not have any details to be disclosed as required under Paragraph 6.1.66, Chapter 6 of the Euronext Dublin Listing Rules and Paragraph 9.6.13, Chapter 9 of the UK Listing Rules.

 

Board structure

Following Gabriella's appointment, the Board will comprise of 13 members including, the Chairman, two Executive Directors, three representatives from Tirlán Co-operative Society Limited and seven Independent Non-Executive Directors. Female representation on the Board will increase to 46% including five of the seven Independent Non-Executive Directors.

 

ENDS

For further information contact

Glanbia plc +353 56 777 2200

Liam Hennigan, Group Secretary & Head of Investor Relations: +353 86 046 8375

Martha Kavanagh, Head of Corporate Communications: +353 87 646 200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAESDEEPDEAA
Date   Source Headline
4th Mar 202212:04 pmRNSDirector/PDMR Shareholding
4th Mar 20227:00 amRNSTransaction in Own Shares
3rd Mar 20226:25 pmRNSGlanbia launches share buy-back of up to EUR50m
3rd Mar 20228:32 amRNSGlanbia launches share buy-back of up to EUR50m
3rd Mar 20227:00 amRNSGlanbia Full Year 2021 Results
2nd Mar 20227:00 amRNSTransaction in Own Shares
2nd Mar 20227:00 amRNSTransaction in Own Shares
1st Mar 20224:40 pmRNSSecond Price Monitoring Extn
1st Mar 20224:38 pmRNSPrice Monitoring Extension
1st Mar 20227:00 amRNSTransaction in Own Shares
28th Feb 20223:25 pmRNSTotal Voting Rights
28th Feb 20227:00 amRNSTransaction in Own Shares
25th Feb 20223:26 pmRNSResult of Meeting
25th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20224:33 pmRNSDirectorate Change
24th Feb 20227:00 amRNSTransaction in Own Shares
23rd Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTransaction in Own Shares
21st Feb 20227:00 amRNSTransaction in Own Shares
18th Feb 20227:00 amRNSTransaction in Own Shares
17th Feb 20227:00 amRNSTransaction in Own Shares
16th Feb 20227:00 amRNSTransaction in Own Shares
15th Feb 20224:41 pmRNSSecond Price Monitoring Extn
15th Feb 20224:36 pmRNSPrice Monitoring Extension
15th Feb 20223:20 pmRNSHolding(s) in Company
15th Feb 20227:00 amRNSTransaction in Own Shares
14th Feb 20227:00 amRNSTransaction in Own Shares
11th Feb 20227:00 amRNSTransaction in Own Shares
9th Feb 20227:00 amRNSTransaction in Own Shares
8th Feb 20227:00 amRNSTransaction in Own Shares
7th Feb 20227:00 amRNSTransaction in Own Shares
4th Feb 20227:00 amRNSTransaction in Own Shares
3rd Feb 20227:00 amRNSTransaction in Own Shares
2nd Feb 20227:00 amRNSTransaction in Own Shares
1st Feb 20223:15 pmRNSNotice of EGM - 25 February 2022
1st Feb 20227:00 amRNSTransaction in Own Shares
31st Jan 20222:20 pmRNSTotal Voting Rights
31st Jan 20227:00 amRNSTransaction in Own Shares
28th Jan 20224:35 pmRNSPrice Monitoring Extension
28th Jan 20227:00 amRNSTransaction in Own Shares
27th Jan 20227:00 amRNSTransaction in Own Shares
26th Jan 20227:00 amRNSTransaction in Own Shares
25th Jan 20227:00 amRNSTransaction in Own Shares
25th Jan 20227:00 amRNSHolding(s) in Company (Replacement)
24th Jan 20224:06 pmRNSHolding(s) in Company
24th Jan 20223:03 pmRNSHolding(s) in Company
24th Jan 20227:00 amRNSTransaction in Own Shares
21st Jan 20227:00 amRNSTransaction in Own Shares
20th Jan 202212:11 pmRNSTransaction in Own Shares
20th Jan 202211:58 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.